Announcement
21 Dec 2021
On 21 December 2021, the EIB provided financing worth EUR 15 million (USD 17 million) to support Austrian company Innovacell's development of personalised cell therapies for the treatment of incontinence.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
21 Dec 2021
Revocation date:
No revocation date
Announced: 21 Dec 2021
State loan
In force
The EIB's EUR 15 million (approx. USD 17 million) loan with Innovacell signed on 21 December 2021 was backed by the European Guarantee Fund (EGF).
The EGF was created in April 2020 by the Eurogroup (...
Sign in to see more
Announced: 21 Dec 2021
State loan
In force
On 21 December 2021, the European Investment Bank (EIB) and Austrian company Innovacell Ag signed an agreement worth EUR 15 million (approx. USD 17 million) to support Innovacell's development of pers...
Sign in to see more
Related State Acts
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70643
interventions
194
jurisdictions
Harmful Trade Policy Interventions: Medical Goods
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7346
interventions
152
jurisdictions